Integrative Health Technologies, Inc. (IHTI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2009 | 38.69 Thousand USD | 0.0% |
| 2006 | 37.18 Thousand USD | -32.6% |
| 2005 | 55.17 Thousand USD | -97.83% |
| 2004 | 2.53 Million USD | 371.25% |
| 2003 | 538.63 Thousand USD | 3068.44% |
| 2002 | 17 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2009 FY | 38.69 Thousand USD | 0.0% |
| 2007 Q2 | 151.8 Thousand USD | 204.36% |
| 2007 Q1 | 49.87 Thousand USD | 282.29% |
| 2007 Q3 | 38.38 Thousand USD | -74.71% |
| 2006 Q1 | 255.12 Thousand USD | 149.43% |
| 2006 FY | 37.18 Thousand USD | -32.6% |
| 2006 Q4 | 13.04 Thousand USD | -75.01% |
| 2006 Q3 | 52.2 Thousand USD | 274.5% |
| 2006 Q2 | 13.94 Thousand USD | -94.54% |
| 2005 Q1 | 435.14 Thousand USD | -63.96% |
| 2005 FY | 55.17 Thousand USD | -97.83% |
| 2005 Q4 | -516.17 Thousand USD | -478.97% |
| 2005 Q3 | 136.2 Thousand USD | 500.06% |
| 2005 Q2 | 22.69 Thousand USD | -94.78% |
| 2004 Q4 | 1.2 Million USD | 250.32% |
| 2004 Q2 | 343.48 Thousand USD | -56.19% |
| 2004 Q1 | 784.09 Thousand USD | 89.66% |
| 2004 FY | 2.53 Million USD | 371.25% |
| 2004 Q3 | 344.67 Thousand USD | 0.35% |
| 2003 Q2 | - USD | -100.0% |
| 2003 FY | 538.63 Thousand USD | 3068.44% |
| 2003 Q1 | 3582.00 USD | 463.65% |
| 2003 Q4 | 413.43 Thousand USD | 239.93% |
| 2003 Q3 | 121.62 Thousand USD | 0.0% |
| 2002 FY | 17 Thousand USD | 0.0% |
| 2002 Q4 | -985.00 USD | -152.56% |
| 2002 Q3 | 1874.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 103.115% |
| Arrayit Corporation | -3.62 Million USD | 101.068% |
| Atlantic International Corp. | -5.73 Million USD | 100.675% |
| Biocept, Inc. | -31.98 Million USD | 100.121% |
| Bioqual, Inc. | -19.63 Thousand USD | 297.016% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 105.011% |
| DermTech, Inc. | -103.73 Million USD | 100.037% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 99.998% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 100.186% |
| iMD Companies, Inc. | -175.44 Thousand USD | 122.052% |
| IDenta Corp. | -1499.00 USD | 2681.054% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 98.62% |
| InVitro International | -25.33 Thousand USD | 252.69% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 100.543% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 166.578% |
| Medical Imaging Corp. | -819.48 Thousand USD | 104.721% |
| NovelStem International Corp. | -3.52 Million USD | 101.097% |
| Optigenex Inc. | 1.39 Million USD | 97.218% |
| PharmChem, Inc. | 973.14 Thousand USD | 96.024% |
| Proteome Sciences plc | -1.62 Million USD | 102.387% |
| Response Genetics, Inc | -21.37 Million USD | 100.181% |
| Rennova Health, Inc. | -1.4 Million USD | 102.745% |
| RushNet, Inc. | -684.7 Thousand USD | 105.651% |
| ScreenPro Security Inc. | -2.59 Million USD | 101.492% |
| Stella Diagnostics Inc. | -11.42 Million USD | 100.339% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 100.499% |
| Todos Medical Ltd. | -9.74 Million USD | 100.397% |